Archive for June, 2006封存2006年6月

Special Camp for Diabetic Children to Learn and Understand How to Manage the Disease特別營糖尿病兒童的學習和理解如何管理疾病

Thursday, June 29th, 2006 週四, 2006年6月29日

Campers (6 to 15 years old who have diabetes or are at risk of developing the disease) have spent the week hiking at Camp Tyler, fishing, swimming at Tyler Junior College, practicing archery, making bird feeders, riding horses and learning how to manage their diabetes.營( 6至15歲的人患有糖尿病或處於危險的發展中國家疾病)已用了一周的遠足在營泰勒,釣魚,游泳,在泰勒初級學院,練射箭,使鳥類餵食器,騎馬和學習如何管理他們的糖尿病。

Students Rally to Create Awareness on Diabetes on the Occasion of World Diabetes Day學生集會,創造意識,對糖尿病在紀念世界糖尿病日

Thursday, June 29th, 2006 週四, 2006年6月29日

Star Health and Allied Insurance conducted a students rally to create awareness on diabetes in Chennai yesterday on the occasion of World Diabetes Day.明星健康和專職保險進行了一次學生集會,創造意識,對糖尿病在Chennai昨天在紀念世界糖尿病日。 The rally, which was flagged off by Director General of Police Mukherjee, saw around 200 NSS volunteers from various city colleges taking part in it.集會上,這是標幟小康,由總幹事警方慕克吉,看到大約200名新高中志願人員來自不同城市的高校考慮參與其中。

Allergan’s Intraocular Pressure Drug Lumigan Received FDA Approval阿勒的眼內壓藥物lumigan收到了FDA的批准

Thursday, June 29th, 2006 週四, 2006年6月29日

The FDA has approved Allergan’s once-daily prescription eye drop Lumigan as a first-line treatment for elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension. FDA已批准阿勒的一次,每天的處方眼藥水lumigan作為第一線治療為高眼壓的壓力與開角型青光眼或高眼壓症。

Success Achieved Through Two different Stem cell Treatment Procedure for Spinal Cord Injury Patients所取得的成功,通過兩個不同的幹細胞治療的程序,脊髓損傷患者

Thursday, June 29th, 2006 週四, 2006年6月29日

Shenzhen Beike Biotechnology Co., Ltd. announced the successful treatment of two similar spinal cord injury patients using two different procedures that involved umbilical cord stem cells.深圳beike生物技術有限公司,宣布成功治療過兩次類似的脊髓損傷患者使用兩種不同的程序,所涉及的臍帶血幹細胞。
One method involved surgical transplantation of stem cells directly into the spinal cord, while the other patient received the stem cells without surgery.一方法所涉及的手術幹細胞移植直接進入脊髓,而其他病人接受幹細胞在沒有手術。 The announcement was made following a […]公佈了以下一[ … … ]

Rural India Facing More Diabetes印度農村地區面臨更多的糖尿病

Thursday, June 29th, 2006 週四, 2006年6月29日

The George Institute for International Health reports that populations in rural India may be set for an epidemic of diabetes.喬治國際問題研究所的報告認為,健康的人口在農村印度可能會訂定一個流行的糖尿病。

The study, of 4,500 individuals, was conducted in 20 villages from the Godavari regions of Andhra Pradesh.研究, 4500個人,進行了在20個村莊從哥達瓦里地區的安得拉邦。 Of those with diabetes, 67 percent were taking sugar lowering tablets, 3 percent were using insulin and 46 percent […]這些糖尿病患者中,有67 %的人考慮降低糖片, 3 %的人使用胰島素和46 % , [ … … ]

GPs Treatment for Type 2 Diabetes Patients全球定位系統治療2型糖尿病患者

Thursday, June 29th, 2006 週四, 2006年6月29日

A new research says that up to 60 per cent of Irish people with type 2 diabetes receive most of their treatment from their GP.一項新的研究指出,高達百分之六十的愛爾蘭人與2型糖尿病的接收大部分的治療從他們的家庭醫生。

Over 20 per cent of people with type 1 diabetes are mostly card for by their GP, according to a report in the April issue of the Irish Medical Journal.超過20 %的人與1型糖尿病大多是卡由他們的家庭醫生,據報導,在2005年4月的問題,愛爾蘭的醫學雜誌。
The study […]研究[ … … ]

Catholic Church opposed Embryonic Stem Cell Research And Declared to Excommunicate Scientists天主教會反對胚胎幹細胞研究,並宣布向excommunicate科學家

Thursday, June 29th, 2006 週四, 2006年6月29日

The Catholic Church declared that it will excommunicate scientists who conduct embryonic stem cell research because it involves the destruction of human life and thus expressed its opposition to the said research.天主教教會宣布,它將excommunicate科學家進行胚胎幹細胞研究,因為它涉及破壞人類生活的,因此表示反對這項研究說。
Cardinal Alfonso Lopez Trujillo, head of the Vatican department dealing with family affairs told Catholic publication Famiglia Cristiana that “destroying human embryos is equivalent […]紅衣主教阿方索洛佩斯特魯希略,團長,梵蒂岡署處理家庭事務部告訴天主教刊物famiglia cristiana “摧毀人類胚胎等於[ … … ]

Rabbis Support Missouri Stem Cell Research and Cures Initiative拉比支持密蘇里州幹細胞研究和治療的倡議

Thursday, June 29th, 2006 週四, 2006年6月29日

The Missouri Stem Cell Research and Cures Initiative which has been voted unanimously by the St. Louis Rabbinical Association, would “ensure Missouri patients have access to any therapies and cures, and allow Missouri researchers to conduct any research, permitted under federal law; ban human cloning or attempted cloning; require expert medical and public oversight and […]密蘇里幹細胞研究和治療的倡議,已全票通過由聖路易斯猶太教協會,將“確保密蘇里州的病人有機會出席任何療法和醫治,並允許密蘇里州的研究人員進行任何研究,准許根據美國聯邦法律;禁止人類克隆或企圖克隆;需要醫學專家和公眾的監督和[ … … ]

Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration第一階段和第二臨床試驗的藥物evizon濕年齡相關性黃斑變性

Wednesday, June 28th, 2006 週三, 2006年6月28日

Biopharmaceutical company Genaera Corporation has commenced a multi-center phase II clinical trial to explore the efficacy and safety of higher doses of its investigational drug Evizon for the treatment of the eye disease, wet age-related macular degeneration.生物製藥公司genaera公司已展開了一項多中心II期臨床試驗,探索的療效和安全性較高劑量的藥物,其evizon用於治療眼科疾病,濕年齡相關性黃斑變性。
The study is designed to evaluate up to 140 patients with wet age-related macular degeneration (AMD) treated with Evizon […]這項研究旨在評估高達140例,與濕年齡相關性黃斑變性( AMD )治療evizon [ … … ]

India-Nepal Friendship Eye Camp in Various Districts of Nepal印度-尼泊爾的友好眼科陣營,在不同地區尼泊爾

Wednesday, June 28th, 2006 週三, 2006年6月28日

The Nepal Netra Jyoti Sangh ( NNJS) and the Embassy of India in Nepal have signed two Memoranda of Understanding (MoU) in connection with conducting Nepal-India Friendship Eye Camp in various districts of Nepal.在尼泊爾的Netra jyoti sangh ( nnjs )和駐華使館,印度在尼泊爾已簽署了兩個諒解備忘錄(備忘錄)在結合進行尼泊爾-印度友好眼科陣營,在不同地區尼泊爾。
As per the MoU signed on Tuesday, the Indian Embassy is to provide 11.3 million Nepali rupees (161,428 US dollars) to carry […]作為每簽署的諒解備忘錄於週二,印度駐華使館是提供1130.0萬尼泊爾盧比( 161428美元)進行[ … … ]